Pituitary apoplexy due to thyroxine therapy in a patient with congenital hypothyroidism

dc.authorscopusid8678198300
dc.authorscopusid35387601800
dc.authorscopusid35489765100
dc.authorscopusid16231562400
dc.authorscopusid16021207900
dc.authorscopusid15921923000
dc.authorscopusid23994048900
dc.contributor.authorTutanc, Murat
dc.contributor.authorAltas, Murat
dc.contributor.authorYengil, Erhan
dc.contributor.authorUstun, Ihsan
dc.contributor.authorDolapcioglu, Kenan S.
dc.contributor.authorBalci, Ali
dc.contributor.authorSefil, Fatih
dc.date.accessioned2024-09-19T15:49:47Z
dc.date.available2024-09-19T15:49:47Z
dc.date.issued2013
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description.abstractA 24-year-old woman was admitted with general weakness, umbilical swelling, developmental delay, speech disorder, constipation, gait problem. Her findings were umbilical hernia, xerosis, dry hair, and short stature. After thyroxine treatment, she also had headache, vomiting, and palpitation, lack of appetite, and sleep disturbance. Pituitary magnetic resonance imaging revealed a heterogeneous mass at the central part of the gland on coronal section and it was interpreted as pituitary apoplexy. In the current case, the patient with congenital hypothyroidism (CH) developed pituitary apoplexy (PA) after thyroxine therapy. Therefore, it is suggested that the complaints were related to PA rather than adrenal insufficiency. Here we describe a case report evaluating PA in a patient with thyrotrophic pituitary adenoma due to CH. To the best of our knowledge, this is the first case in terms of PA associated with CH after thyroxine therapy in the literature.en_US
dc.identifier.endpage311en_US
dc.identifier.issn0125-9326
dc.identifier.issue4en_US
dc.identifier.pmid24448336en_US
dc.identifier.scopus2-s2.0-84921024999en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage306en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12483/15410
dc.identifier.volume45en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.relation.ispartofActa medica Indonesianaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAdulten_US
dc.subjectCongenital Hypothyroidismen_US
dc.subjectDiagnosis, Differentialen_US
dc.subjectDisease Managementen_US
dc.subjectFemaleen_US
dc.subjectGlucocorticoidsen_US
dc.subjectHormone Replacement Therapyen_US
dc.subjectHumansen_US
dc.subjectMagnetic Resonance Imagingen_US
dc.subjectPituitary Apoplexyen_US
dc.subjectPituitary Glanden_US
dc.subjectPituitary Neoplasmsen_US
dc.subjectThyroxineen_US
dc.subjectTreatment Outcomeen_US
dc.subjectWithholding Treatmenten_US
dc.subjectglucocorticoiden_US
dc.subjectthyroxineen_US
dc.subjectadulten_US
dc.subjectcase reporten_US
dc.subjectchemically induceden_US
dc.subjectcongenital hypothyroidismen_US
dc.subjectdifferential diagnosisen_US
dc.subjectdisease managementen_US
dc.subjectfemaleen_US
dc.subjecthormone substitutionen_US
dc.subjecthumanen_US
dc.subjecthypophysisen_US
dc.subjectnuclear magnetic resonance imagingen_US
dc.subjectpathologyen_US
dc.subjectpathophysiologyen_US
dc.subjectPituitary Apoplexyen_US
dc.subjectPituitary Neoplasmsen_US
dc.subjecttreatment outcomeen_US
dc.subjecttreatment withdrawalen_US
dc.titlePituitary apoplexy due to thyroxine therapy in a patient with congenital hypothyroidismen_US
dc.typeArticleen_US

Dosyalar